Lim V S, Zavala D C, Flanigan M J, Freeman R M
J Clin Endocrinol Metab. 1986 May;62(5):863-8. doi: 10.1210/jcem-62-5-863.
To assess the metabolic effects of T4 and T3, we measured serum total T4 (TT4), free T4 (FT4), total T3 (TT3), TSH, and basal oxygen uptake (VO2) in eight normal subjects in the basal state and after treatment with L-T3 (T3) and sodium ipodate for 2 weeks. T3 treatment resulted in a rise of serum TT3 from a baseline of 137 +/- 16 (+/- SE) to a peak of 239 +/- 15 ng/dl. Serum TT4 declined from 8.14 +/- 0.56 to 6.08 +/- 0.43 micrograms/dl, FT4 from 1.59 +/- 0.13 to 1.03 +/- 0.05 ng/dl, and TSH from 1.74 +/- 0.24 to 0.56 +/- 0.16 microU/ml. Basal VO2 increased from 2.66 +/- 0.11 to 3.15 +/- 0.09 ml/kg X min. Ipodate, on the other hand, led to a lower serum TT3 concentration (102 +/- 21 ng/dl), higher serum TT4 and FT4 (9.59 +/- 0.5 micrograms/dl and 1.91 +/- 0.13 ng/dl, respectively), and elevated TSH (3.64 +/- 0.14 microU/ml). Basal VO2 was reduced to 2.44 +/- 0.06 ml/kg X min. Linear regression analysis revealed an excellent positive correlation between serum TT3 and basal VO2 (n = 25; r = 0.747; P less than 0.001) and a significant negative correlation between serum TT3 and TSH (n = 26; r = -0.526; P less than 0.01). Serum TT4 and FT4 correlated negatively with VO2 and positively with serum TSH. The higher T4 level during ipodate treatment was associated with lower VO2 and higher TSH, and vice versa when T4 was suppressed while receiving T3. When ipodate was given concomitantly with T3 to five subjects, only the effects of T3, characterized by increased VO2 and decreased TSH, were evident. These data indicate that both basal VO2 and serum TSH are sensitive indices of thyroid hormone activities. The latter gives only the directional change (hyper- or hypothyroidism), while the former more accurately quantitates the magnitude of the derangement. Moreover, it appears that in man, T3, and not T4, is the primary hormone that regulates thermogenesis and TSH secretion.
为评估T4和T3的代谢效应,我们测量了8名正常受试者在基础状态下以及用L-T3(T3)和碘番酸钠治疗2周后的血清总T4(TT4)、游离T4(FT4)、总T3(TT3)、促甲状腺激素(TSH)和基础氧摄取量(VO2)。T3治疗使血清TT3从基线水平137±16(±标准误)ng/dl升至峰值239±15 ng/dl。血清TT4从8.14±0.56微克/分升降至6.08±0.43微克/分升,FT4从1.59±0.13纳克/分升降至1.03±0.05纳克/分升,TSH从1.74±0.24微国际单位/毫升降至0.56±0.16微国际单位/毫升。基础VO2从2.66±0.11毫升/千克×分钟增至3.15±0.09毫升/千克×分钟。另一方面,碘番酸钠导致血清TT3浓度降低(102±21 ng/dl),血清TT4和FT4升高(分别为9.59±0.5微克/分升和1.91±0.13纳克/分升),TSH升高(3.64±0.14微国际单位/毫升)。基础VO2降至2.44±0.06毫升/千克×分钟。线性回归分析显示血清TT3与基础VO2之间存在良好的正相关(n = 25;r = 0.747;P < 0.001),血清TT3与TSH之间存在显著负相关(n = 26;r = -0.526;P < 0.01)。血清TT4和FT4与VO2呈负相关,与血清TSH呈正相关。碘番酸钠治疗期间较高的T4水平与较低的VO2和较高的TSH相关,而在接受T3治疗时T4被抑制则情况相反。当碘番酸钠与T3同时给予5名受试者时,仅出现以VO2增加和TSH降低为特征的T3效应。这些数据表明基础VO2和血清TSH都是甲状腺激素活性的敏感指标。后者仅给出方向性变化(甲状腺功能亢进或减退),而前者更准确地量化紊乱的程度。此外,似乎在人类中,调节产热和TSH分泌的主要激素是T3而非T4。